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The Service Users Rights in Action (CAN and SURIA) is an independent group consisting of service users, 
former service users, medical professionals, service providers and community activists. We have been 
continuously carrying out research that highlights the many difficulties encountered by the Irish drug service 
user for almost a decade, since 2012. This Report, entitled “Nothing About Us Without Us”, is informed by 
121 surveys that demonstrate the current service user voice regarding their experiences and treatment as 
they use modern day methadone services.  
It is both a stand-alone piece of research of current methadone maintenance treatment (MMT) (Foucault 
2008) practice and also part of the longer-term monitoring by SURIA of the progressive realisation of the 
right to adequate health for those who avail of MMT. As a stand-alone piece, this research explores the 
current life narrative of the MMT client, however as a broader part of the long-term monitoring of the 
realisation of rights-based treatment for MMT clients that SURIA has undertaken, this report is the latest of 
four sets of data that SURIA have collected since 2012. The advantage of drawing from multiple sets of data 
is that it highlights the progression or regression of rights-based treatment, demonstrates trends and 
patterns in treatment and enables SURIA to seek accountability from services and key stakeholders. It informs 
our monitoring of MMT from the platform of human rights. The use of Participatory Action Research, which 
will be discussed, allows us to frame practices in a way that this can be achieved. 
The report is presented in two parts.  
Part One:  This presents the data from the fourth round of peer led research conducted by SURIA in late 
2019/early 2020. This research sought to represent the lived experience of the MMT client through the 
surveying of 121 MMT clients. The analysis of this data through the lens of human rights, evidence-based 
practice and the international evidence base presents the Irish system as one in need of serious reform. 
Clients, many desensitised or unaware of the ethos and objectives of holistic methadone care are staying on 
methadone longer, providing more urine samples, have a low quality of life and are rarely enjoying a life 
where their rights are being realised and a meaningful form of recovery is an attainable goal. Also, many feel 
controlled, surveyed and stated that their lives and choices were severely limited by the duties and 
obligations which their clinic required. 
Part Two: This section locates this standalone piece of research into the longer-term monitoring and 
campaigning work of SURIA. We describe how PAR is ideally suited to the objectives of this Report, given that 
it is a cyclic research methodology that excels in emancipatory, monitoring research practice. We also 
compare and contrast the evidence emerging from this round of research with baseline data gathered in 
2012, 2017 and revisited in 2017/18 as part of a Public Sector Duty Pilot Project under the auspices of The 










MMT is currently the most widely used mode of treatment for Irish opiate users, with The European 
Monitoring Centre of Drugs and Drug Addiction (EMCDDA) stating that as per 2019, over 10,000 clients were 
actively availing of this mode of treatment in the State, (EMCDDA 2019). Almost from the inception of the 
Methadone Protocol (1998), as early as 2003 allegations of poor treatment (Lawless & Cox 2003, UISCE 2003) 
and human rights violations (ICCL 2015) began to emerge, from service users in the former and key rights 
monitoring stakeholders in the latter. In 2010, the HSE funded an evaluation of MMT and the practices it 
employed, (Farrell & Barry 2010). This Report, colloquially known as The Farrell Report was a damning 
indictment of Irish MMT practices and in particular, its continued overuse of urinalysis. In short, the Report 
maintained that Irish MMT had commenced in accordance with the international evidence base in 1998, 
however it had since failed to evolve as per best practice.  
 It was the relative failure of the HSE to change any of the practices that their own Report had been so critical 
of which led to the formation of SURIA and our first round of research, in 2012. Our second round of research 
commenced in 2017. Both sets of earlier research, alongside Our Lives, Our Voice, Our Say (SURIA 2018, a 
report published at the end of the pilot Public Sector Duty Project with the Irish Human Rights and Equality 
Commission (IHREC) presented a picture, which was also discussed in academic literature (Moran et al. 2018) 
that Irish MMT was failing many clients, was not consistent with the International evidence and was also in 
violation of a number of human rights instruments, primarily The Public Sector Duty, The Right to Health and 
The Right to Participate. 
The publication of Our Lives, Our Voice, Our Say, which was again informed by peer-led research by SURIA, 
stated that “serious human rights and equality concerns based on the lived experience of service users have 
been expressed”, (SURIA 2018:5). For SURIA, as a group that monitors the human rights of drug service users, 
this was confirmation that rights were not in the process of progressive realisation, as per UN International 
Convention of Economic, Social and Cultural Rights, which was ratified by the State in 1976. Article 2 allowed 
for States to provide rights in accordance with their abilities, both economically and politically. As part of 
monitoring the service user journey of MMT clients, SURIA also held two dialogue events in 2015 and 2016. 
Dialogue seeks the co-creation of knowledge through the sharing of perspectives from within the service 
user/service provider relationship, (Bohm 2004). These highly successful events provided an opportunity for 
change and were attended by many key stakeholders, including Minister Catherine Byrne, who at the time 
was Minister of State overseeing the National Drug Strategy. It was the early rounds of research and these 
dialogue events that helped SURIA frame our campaign around four distinct shortcomings that were a 
constant finding in all our research. These were: 
1. over reliance on testing (and in particular supervised urinalysis),  
2. lack of choice regarding treatment,  
3. lack of meaningful review and 
4. absence of an independent and robust avenue for complaints within clinics 
These four tenets or shortcomings, which emerged from multiple rounds of research became the core 
priorities of our research strategies. 
Our third round of research resulted in the 2018 publication of Our Lives, Our Voice, Our Say in conjunction 
with the Irish Human Rights and Equality Commission. SURIA put forward twenty-eight recommendations 




experience of the MMT client. As such, we have remained steadfast in our objective to improve the lived 
experience of the contemporary MMT client in Ireland through the continued monitoring of the efficacy of 
the publication’s recommendations and continued research. Through prolonged engagement with those who 
use a form of Public Health which rarely leads to real improvement in the quality of life of clients (Moran et 
al.  2018), we have continuously attempted to illustrate the lived experience of the MMT client as an 
individual whose life is often constrained by drug services in the guise of sanction and control. Our four 
rounds of research have each described a life of little choice, a failure to improve quality of life and 
highlighted human rights concerns and a range of invasive procedures that combine to advance the harsh 





2. Nothing About Us Without Us – 2019/2020 
 
This Report now takes as its point of departure our latest research informed by data collected by our 
members in 2019/2020. The Report highlights the lives of the many clients who speak of being controlled by 
their service and the many rules and regulations which they must abide by if they are to continue to be 
treated. MMT has been described as a mode of social control that the client must adhere to, if one is avoid 
being sanctioned or punished (Harris & McElrath 2012). While we do not under-estimate the difficulties that 
professionals encounter in what can often be a challenging setting for health professionals, SURIA advocate 
for dignity and respect in all service user engagements, the implementation of evidence-based practice in 
these engagements and for quality of life to be the principal indicator of efficacious MMT. 
This Report is informed by data collected from 121 participants using surveys which consisted of fifty-three 
questions including open ended question, Likert Scale (eg on a scale of 1 to 5….) and closed questions. We 
employed purposive sampling, drawing from our relationships with several key actors in a number of Irish 
harm reduction services in order to establish our research population. The surveys produced sufficient 
quantitative and qualitative data to continue with our agenda and aim of monitoring Irish MMT through a 
human rights lens towards the progressive realisation of Service User human rights to dignity, health and 
participation in their own health care planning. 
2.1 The Service User Profile: The Ageing Irish MMT Client 
As per standard practice the opening questions were based upon demographics, including age, gender, 
location, length of time in treatment, etc. Our research found that this information suggests the typical Irish 
MMT client is now older and in treatment longer, which arguably demonstrates that service users are now 
being prevented from re-integrating into society post treatment. As such MMT becomes a mode of treatment 
from which few emerge. 
 


























FIGURE  2: AMOUNT OF TIME ENGAGING WITH MMT (YEARS) 
 
The ageing Irish MMT patient base has been explored in Irish academia (Carew & Comiskey 2018) and is 
arguably a consequence of the shortcomings regarding reintegration and quality of life. Our research found 
that 83% of the participants were aged between 36 and 60, while half (51%) had been engaging with their 
services for 16 years or more. From these figures, the evidence states that a large majority of our research 
participants had spent over half their life on methadone. This becomes problematic when the evaluation of 
services is examined. If clients maintain that their services are producing a higher standard of living and 
stimulating re-integration, the length of time on methadone could be argued to be unproblematic. It could 
be argued that denying treatment or reducing the length of treatment could have led to more harm and an 
early death. However, the overall evaluation of the service user life experience was routinely described as 
harmful, life inhibiting and undignified. Therefore, prolonged engagement with such a service is argued to do 
little to advance better outcomes in the lives of clients. 61% of our cohort reported that they were unhappy 
with their treatment provision, and this is more alarming when one considers that 97% of participants 
































FIGURE  3: THE LACK OF TREATMENT CHOICE 
        
 
SURIA MAINTAIN THAT CLIENTS SHOULD RETAIN THE RIGHT TO ENGAGE WITH MMT FOR AS LONG AS THEY SEE FIT. 
HOWEVER, WHEN THESE SHORTCOMINGS ARE HIGHLIGHTED, COMBINED WITH THE LOW NUMBER OF CLIENTS WHO 
COMPLETE MMT, THE OUTCOME IS A LARGE CLIENT BASE IN LONG TERM TREATMENT IN WHICH THEY ARE BEING 
MISTREATED, FAILING TO BE REHABILITATED OR RE-INTEGRATED AND BEING DENIED THE ADVANTAGES OF EVIDENCE-
BASED HARM REDUCTION. HARM REDUCTION THAT IS INFORMED BY EVIDENCE OFTEN REDUCES THE USE OF ILLICIT 
DRUGS, BLOOD BORNE DISEASE, MORTALITY RATES AND CRIME, (WARD, MATTICK & HALL 1998, KLEBER 1998, KEANE 
2003). THE MODEL ITSELF EMANATES FROM THEN PIONEERING WORK, IN 1980’S LIVERPOOL THAT CONCENTRATED ON 
REDUCING THE HARM OF DRUG USE AS OPPOSED TO DRUG USE PER SE , (NEWCOMBE 1992 SINGLE 1995), PROMOTING 
AN AMORAL, NON-JUDGEMENTAL RECOVERY MODEL THAT INVOLVED MMT, VEIN CARE, NEEDLE EXCHANGE AND 
OUTREACH. THIS IS FURTHER MAGNIFIED WHEN WE DISCUSS URINALYSIS AND THE OVER RELIANCE OF SAMPLING.  
 
2.2 Urinalysis – The Evidence Base, Cost and Monitoring of Supervised 
Sampling 
 
SURIA consider supervised urinalysis to be a minor, first victory of our campaign against the many invasive 
procedures that are part of Irish MMT. Our 2018 work with IHREC was closely followed by a change in policy, 
as the HSE directed that supervised sampling was “not required in routine clinical practice” in MMT. Despite 
this change, our research demonstrates that supervised urinalysis is still mandatory in some clinics (5%). Also, 
although the vast majority of clinics are working in accordance with this directed change, urinalysis is still 
being practiced as a mandatory obligation in a large number of clinics. A closer analysis shows that 67% are 
providing a sample at least once a week and within this population, one in five are providing two to three a 
week. This has been consistent in all of our research, with the exception of a sharp increase in those 
submitting 2/3 samples per week between 2012 and 2017. Evidence suggests that supervised urinalysis was 
costing Irish MMT services 5.5 million Euro per annum in 2009, (O’Súilleabháin 2009). It is reasonable to 
assume that a decade’s inflation, and this increase, has further added to this cost.  
3.3%
96.7%
0.0% 20.0% 40.0% 60.0% 80.0% 100.0% 120.0%
Yes
No




In an emergent pandemic worldview, SURIA maintain that this practice must be re-assessed, with the limited 
resources that finance MMT being better employed increasing the efficacy of treatment, through training 
and the provision of a greater number of ancillary services to promote re-integration. 
The centrality of sampling, which in the case of Irish MMT is almost always urinalysis, is argued to still be a 
key factor in what we maintain to be the various shortcomings of the human experience of methadone 
treatment.  SURIA argue, as per Farrell and Barry (2010) that Irish MMT has become too entrenched in 
urinalysis and therefore abstinence has become a key indicator of successful treatment. Our point here is 
that reintegration, quality of life and choice appear not to be important outcomes in the lives of clients. As 
opposed to meaningful review, progressive therapeutic alliances and treatment based on dignity, respect 
and equality; testing, sanction and discipline routinely dominate the lives of methadone patients. This is an 
example of the propensity of Irish MMT service provision to again work at odds to the international evidence 
base. Ward, Mattick & Hall (1997, 1998) are regarded as key advocates of evidence informed methadone 
treatment and their work has long espoused that urinalysis does not reduce drug use.  
SURIA ARGUE THAT ABSTINENCE AND PROHIBITION ARE STILL THE PERVADING GOALS OF IRISH HARM REDUCTION. THIS 
VIOLATION OF THE KEY AIM OF HARM REDUCTION IS A POSSIBLE FACTOR IN THE POOR OUTCOMES THAT ARE ROUTINELY 
PRODUCED BY OUR METHADONE SERVICES.  
 
FIGURE  4: FREQUENCY OF URINALYSIS 2019 /2020 
        
2.3 The Poor Quality of Life for the Irish MMT Client: 
From its inception in 1960’s New York, MMT was always intended, like all public health services, to improve 
the quality or standard of life of those who engaged with services, (Dole & Nyswander 1965, 1980). However, 
MMT is now often seen as a method of treatment that disrupts the lives of clients and creates a lifestyle that 
includes visits to doctors, clinics, pharmacies and the various other stakeholders who make up the service, 






















When evaluating their experiences of MMT, a large number of participants responded by stating that they 
felt “controlled”, “chained” or “trapped” by their clinic. As an advocacy group, we argue that there is a 
general feeling of constant observation and inhibition among clients, due to the multiple and repetitive duties 
and obligations that many services demand. Others claimed their “lives had been wasted”, with almost half 
of the participants stating that they did not envision themselves being “on it (MMT) this long” when they 
commenced methadone treatment.  
4% of participants stated that they were either in education, had employment or were engaging with some 
form of training. The majority of participants stated, in open ended questions that MMT had routinely 
restricted any opportunity to engage with any of these important avenues to meaningful rehabilitation and 
a higher standard of living.  
SURIA will always attempt to seek the individual from the statistics and personify our participants. As a 
representative, advocacy group, we see this as vital, thus our primary aims and campaigns seek to improve 
the lived experience of MMT through the promotion of holistic treatment and the monitoring of the human 
rights of the person, in this case the drug service user. Following our prolonged engagement with service 
users,  
SURIA CONTINUE TO MAINTAIN THAT THE QUALITY OF LIFE OF CLIENTS CAN BE IMPROVED THROUGH CHOICE REGARDING 
TREATMENT, DIGNIFIED TESTING, MEANINGFUL REVIEW AND RESPECTFUL TREATMENT PRACTICES THAT INCLUDE AN 
EFFECTIVE AVENUE FOR COMPLAINT. THE PERCEIVED IMPORTANCE OF TESTING AND ABSTINENCE IS ARGUED TO BE OVER-
STATED, FREQUENTLY REPLACING COMMUNICATION BETWEEN SERVICE PROVIDER AND USER AND SOCIAL 
REINTEGRATION. OUR RESEARCH PUTS FORWARD A CLAIM THAT IT IS THE TEST AS OPPOSED TO THE PATIENT THAT IS 
IMPORTANT IN IRISH MMT, RESULTING IN TREATMENT THAT BECOMES DESENSITISED AND INSTRUMENTAL, WITH 
INDIVIDUAL WELL-BEING RARELY ADDRESSED.  
 
2.4 De-personalising the MMT Client – The Lack of Treatment Choice and 
Meaningful Review: 
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When this research explored choice of treatment and care plans, the results continued to suggest that the 
human rights of drug service users in Ireland were not in the process of progressive realisation. In fact, the 
statistics magnified the regression of rights-based treatment. The lack of treatment choice in the sense of 
alternative medications has been discussed, however our research supports the claim that there are also 
restrictions of choice within MMT that act as barriers to progressive change and meaningful treatment. 
Choice within the MMT system is here seen to include detoxification and more indirectly, some of the 
obligations that preclude the autonomy of the client—continual urinalysis, visits to clinics and/or pharmacies 
due to the refusal to permit takeaway dosages. 
SURIA ARGUES THAT ABSENCE OF MEANINGFUL, CLIENT CENTRED CARE PLANS IN MANY SERVICES ALSO HAS THE EFFECT 
OF REDUCING CHOICE, WITH THE SERVICE USER BEING CONSTRAINED BY THE DECISIONS OF DOCTORS AND OTHER KEY 
ACTORS WHO OPERATE IN THE PROVISION OF METHADONE AT SERVICE LEVEL. A SUFFICIENT CARE PLAN WOULD ENHANCE 
THE DYNAMIC BETWEEN SERVICE PROVIDER AND USER AND ALLOW FOR THE PRACTICES OF MMT TO BE FRAMED AROUND 
THE LIVES OF CLIENTS. 
 
FIGURE  6: CARE PLANS 
 
However, the vast majority of our participants that were unaware of what a care plan is indicative of a public 
health population that is rapidly becoming desensitised to the shortcomings of contemporary MMT. It is 
unlikely that any other public health patient base are denied meaningful discussion with caregivers regarding 
their aims, objectives, plans and general dispositions regarding the progression of their treatment.  
 
FIGURE  7: PARTICIPANTS WHO WANT CARE PLANS TO INFORM THEIR TREATMENT 
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For those who did understand the dynamics and make-up of a care plan, 70% demonstrated that they 
recognised the advantages this could bring to their treatment, yet they were not available to them through 
their service provider. As such, Irish MMT is argued to constitute medication and little else in the form of 
ancillary care. 
Detoxification is arguably a part of MMT that can be situated as treatment choice and part of a care plan. 
Regarding this, the research demonstrated that 30% of participants were never offered detoxification. While 
within the 70% that had discussed this with their care provider, we find many differing responses in relation 
to who brought up the subject and when was it discussed;  
“I initiated it 6 months ago. I have to bring it up as it is never raised. I feel they do not listen to me.” 
“Me, I asked about it. Quickly disappeared. Very ashamed for asking. Did not want to ask again.” 
“Me. The first time. It is going well. Slow and managed well 
15% were not considered for detox due to “not being ready” with no discussion as to why. A number had 
only discussed this as they commenced their treatment and the subject was not re-visited. This evidence 
suggests that autonomy and choice appears poorly available from Irish MMT and this is magnified by the lack 
of meaningful review and care-plans.  
 













Again, we wish  to highlight that we do not advocate for clients to be rapidly detoxed without careful and 
informed planning between service user and their doctor. As such, it should be an informed decision between 
services and clients, underpinned by treatment history, well-being and most importantly the choice of the 
patient.  
When examining meaningful review, only one in five participants have regular discussion with their service 
provider which offers the opportunity to have a discussion regarding the accumulation of recovery capital1 
in their lives.  
SURIA ARGUE THAT WITHOUT MEANINGFUL DISCUSSION AND THE POSSIBILITY OF ATTRACTIVE ALTERNATIVES TO DRUG 
USE, MMT CAN OFTEN BECOME A BLUNT INSTRUMENT IN THE ACQUISITION OF AN IMPROVED QUALITY OF LIFE. 
FURTHERMORE, MEANINGFUL REVIEW PROMOTES THE RECOVERY CAPITAL THAT IS THE PRECURSOR TO MEANINGFUL 
CHANGE AND SOCIAL REINTEGRATION. WE AT SURIA CAMPAIGN FOR INTERNATIONAL EVIDENCE TO BE THE PRIMARY 
INFORMANT OF PROGRESSIVE MMT. DOLE & NYSWANDER (1967), THE PIONEERS OF THE MODEL DID NOT ADVOCATE 
FOR TOTAL ABSTINENCE. AS SUCH, REINTEGRATION WAS SEEN TO BE THE BACKDROP OF A SERVICE USER EXPERIENCE 
THAT EXHIBITED CHANGE IN THE LIFE OF THE CLIENT. 
 
FIGURE  9: MEANINGFUL REVIEW 
 
1 Recovery Capital is a widely used phrase used to describe the skills, competencies or abilities that are intended to be 
beneficial in the client’s rehabilitation. These can include coping strategies, housing and the skills needed to live a drug 








Have you discussed detoxification or on going methadone 





Fig 9 demonstrates a distinct lack of a meaningful and effective discussion between service provider and user, 
yet Fig 10 clearly suggests that an overwhelming majority of MMT clients have personal goals regarding their 
treatment. But statistics demonstrate a clear shortcoming in what SURIA maintain is a major shortcoming of 
contemporary Irish MMT, the lack of communication, and equal treatment to that of other public health 
services. 
 
FIGURE  10:  PERSONAL GOALS 
 
This data situates MMT as a mode of drug treatment that does not place the needs and life difficulties of the 
client as central to treatment. There is little communication and there appears to be a power imbalance 
within the service provider and user dynamic. With little communication, demonstrated by the lack of review 
and care plans, MMT cannot be considered client centred and holistic, nor does it offer the individualistic 
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2.5  Centrality of Abstinence – MMT as Control 
Personal goals and meaningful discussion are usually replaced with the heightened importance of abstinence. 
With this comes the afore-mentioned allegations from participants of a thinly veiled programme of control. 
As a rights-based peer group, our work is a continuous assessment of the merits of MMT as rights-based 
treatment, as opposed to a form of managing what is often considered a difficult to govern population.  Our 
past and current research supports a claim that MMT is and was being used as “moral medicine”, with 
sanctions and outcomes that extend far beyond the sphere of drug use. Many of these are a corollary of 
having to move clinics, having takeaways reduced and/or increased visits to any of the stakeholders who 
make up the methadone service. These sanctions often place severe restrictions on the lives of clients, some 
which include childcare, the expense of travel and the loss of the ability to work. As such, these measures of 
control are often not obvious, however the inhibitions they place on the lives of clients inform the control 
that has been cited by participants. Social control, according to Cohen is a set of organised practices in 
response to deviance that attempts to morally constrain a population, (1984).  
WE WOULD ARGUE THAT OUR RESEARCH SUGGESTS THAT MMT IS OFTEN EMPLOYED IN THIS WAY. ALTHOUGH THIS IS A 
PROVOCATIVE CLAIM AND THE INTENT OF SERVICES IS DEBATABLE, THE EVIDENCE WE HAVE COLLECTED STRONGLY 
SUSTAINS AN ARGUMENT THAT CLIENTS FEEL CONTROLLED AND INHIBITED FROM LIVING A NORMAL LIFE OF THE HIGHEST 
ATTAINABLE QUALITY. WE HAVE ALSO DISCUSSED THAT MMT HAS A PROPENSITY TO “GOVERN TOO MUCH”, (FOUCAULT 
2008, READ 2009). THIS OVER-EXTENSION OF POWER CAN OFTEN BECOME OPPRESSION, SUPPRESSING THE LIFE OF THE 
CLIENT. THIS IS FURTHER SUSTAINED WHEN WE EXAMINE THE DATA IN FIGURE 11 REGARDING THE CLIENT’S 
PRESENTATION AT THEIR PLACE OF CARE. 92% MUST VISIT THE CLINIC WEEKLY, 46% DAILY AND 23% 2-3 TIMES A WEEK. THIS IS 
AN EXAMPLE OF HOW SERVICES ARE POLICING THE CONDUCT AND DICTATING THE LIVES OF CLIENTS.  
 
FIGURE  11: FREQUENCY AT WHICH PARTICIPANTS MUST ENGAGE IN PERSON WITH THEIR SERVICES 
 
We argue that no client should have to visit services daily, and even those who visit services 2-3 times a week 
have little chance of sustaining a normal life. To risk the overuse of the work of Mayock et al (2018) regarding 
social re-integration, we further argue that housing, work or education and the reconstruction of damaged 


















being alluded to as “places of nuisance” and with the majority of participants stating in open ending survey 
questions that their primary objective was to “get off” methadone, we would argue that the over use of 
clinics for urinalysis and the dispensing of medication, is harmful to the well-being of clients. Many claimed 
that the everyday choice to go visit family or take a few days holidays was rarely, if ever possible. As such, it 
creates a life of repeated visits to doctors, pharmacies and area where the dealing of drugs is an obvious by-
product of circumstance.  
It is these many hidden obligations which combine to restrict the life of Irish MMT clients which is magnified 
by data that describes MMT as a life that is characterised by threats of sanction, invasive procedures, rights 
violations and a distinct absence of an avenue for a meaningful and attractive recovery or life.  
 
2.6 Acceptance or Mistreatment – Collective Trauma: 
Our research has demonstrated that the current Irish methadone system is in need of assessment, reform 
and continuous monitoring from key actors and human rights duty bearers. The provision of methadone 
requires a robust framework which is formed around the needs and lives of service users. That is, service 
users require more autonomy to make key decisions in their own lives regarding to rehabilitation and re-
integration. We at SURIA again draw from the recent work of Paula Mayock et al (2018), who defines 
reintegration as a route to housing, education or employment and the reconstruction of the family unit. With 
a minority of 39% stating that their experience of MMT had been positive having a positive outlook of their 
MMT experience and outcomes, their reasoning was seldom underpinned by life progress and dignified, 
respectful treatment as per Public Sector Duty. These participants framed the apparent benefits of MMT as 
helping reduce crime, not experiencing withdrawal and having “a small bit of normality” in their lives.  
With expectation being so low, the lack of rights often becomes the norm, with stigma, shame and guilt being 
regularly discussed in many of the open-ended questions. A novel finding of this research magnified the lack 
of compassion or recourse for those who have developed problems with the use of benzodiazepines 
(including z-based) and other tablets purchased from the streets. As opposed to compassion and assistance, 
a large number of clients reported that this activity was treated with severe sanctions by clinics, with the 
responses including dose reduction, the removal of take-away doses and the refusal of any assistance. SURIA 
argue that this is a worrying development that must be immediately discussed with key stakeholders in the 
MMT system.  
The normalisation of mistreatment, poor treatment and non-evidence-based treatment is again linked to the 
power of sanction, control and constraint. Some of the outcomes which are mentioned in the research are 
arguably the result of services penetrating too deeply into the lives of clients (Snoek 2015). These include 
health problems (dental problems and “the sweats” being the most common), stigma, shame, the inability 
to work or return to education and the financial cost of engaging with their MMT service. It is these outcomes 
which prevent social re-integration, reduce quality of life and inhibit person centred treatment. It is these 
research outcomes which underpin our argument that MMT services are restricting the recovery it is 
ostensibly attempting to promote. In the process, participants are experiencing what could be termed 
collective trauma with punishment and threats of sanction becoming everyday norms and occurrences.  
Urinalysis is an invasive, aggressive procedure that has been central to our campaigns since our inaugural 
research. What is striking in Figure 12 below, a question that allowed multiple choice answers, is the large 
number of clients who have become “used to it” or feel they “have no choice”. In spite of the practice been 
defined as “degrading”, “undignified” or an obligation in which they “have no choice”, the fact that so many 
participants state they are “used to it” is indicative of the normalisation of mistreatment, the normalisation 
of being treated with little respect or dignity if one is to continue to be treated for their addiction. It is also 
argued that the large number of clients who claim that urinalysis “keeps them on track” reflects the 




instruments of care, as opposed to compassion, respect and rehabilitation, that is discussing and facing the 
cause of addiction.  
SURIA ARGUE THAT FEAR HAS NO PLACE IN RIGHTS-BASED CARE AND WHILE WE ACKNOWLEDGE THE LIMITED 
ADVANTAGES OF TESTING, WE BELIEVE IT SHOULD NOT BE THE MAIN FORM OF ASSESSING OUTCOME, TREATMENT, 
REHABILITATION OR HARM REDUCTION.  
 
FIGURE  12: PARTICIPANTS’ OPINIONS OF URINALYSIS 
 
The modes of control and discipline that we argue to be central to sample centred treatment are magnified 
by the lack of an independent and robust complaints mechanism. It is not beyond reason to state the research 
magnified the relatively negative perception the majority of participants hold pertaining to their treatment. 
The ramifications of urinalysis have been discussed, as have the general negative suppositions regarding both 
the lack of choice in treatment and use of care plans in treatment. These are arguably all intertwined in the 
general evaluation and rating of MMT that informed a distinct question in the survey. 
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Participants were asked to rate the process as a sum of its parts in a scale ranging from 1 to 5, (Lickert Scale). 
As illustrated in Figure 13, just 23% of our research population rated their experience as being very good to 
good. Moreover, the remaining 77% rated their experience of MMT, that is as a form of health care with all 
the discussed variables considered, as average (32%) , poor (27%) or very poor (17%). As such, 45% of 
participants were of the opinion that their experience on MMT was below average. One could argue that 
these statistics advance a disillusioned, alienated and unhappy patient base and moreover, it would be 
expected to inform a high number of complaints that are reflective of this data. However, when our research 
discussed the opportunity for patients to engage with a complaint’s procedure, it was shown that very few 
had, nor were they willing to. 
FOR SURIA, WE FIND THIS INDICATIVE OF A NUMBER OF KEY ISSUES. FIRSTLY, IT DEMONSTRATES THAT THE 
INDEPENDENT AVENUE FOR COMPLAINT, PART OF OUR CORE PRINCIPAL SET, IS BOTH POORLY UNDERSTOOD BY CLIENTS, 
NOR DOES IT INSPIRE THE NECESSARY CONFIDENCE OF CLIENTS.  
 













Overall, how would you describe the experience of being 
on methadone on a scale
24.1%
75.9%
0.0% 20.0% 40.0% 60.0% 80.0% 100.0%
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It must also be stated that among the 24% who claimed they had made complaints, there was a large 
number who considered these complaints to be casual comments to doctors and service providers as 
opposed to official complaints through the recommended complaints procedure and channels. This was 
amplified by the large number of clients who stated they were unaware of procedural obligations of making 
a complaint.  
 




The lack of complaints, and the many participants who stated to have little or no knowledge of the 
complaint’s procedure adds further validity and credibility to our thesis of the desensitising of MMT patients 
to poor treatment provision. 
The further normalisation of the clinic as public health services that seeks to place morality above health and 
behaviour over the client’s life choices further identifies how MMT can and does dehumanise the client, 
creating a particular form of health care with a focus on long term treatment, little progression and no 
attractive alternative to continuous drug use. Our evidence suggests that many clients have internalised and 
are expectant of this form of low-quality care and the life it informs, a form of care that would be 
unacceptable to any other public health population.  
 
FIGURE  16: ANCILLARY SERVICES AND MMT: - WHERE AND BY WHOM ARE THEY OFFERED? 
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Furthermore, our data highlights the different services that participants engage with as they negotiate the 
complex methadone system. Throughout the interviews, the open ended questions made manifest that for 
the vast majority of clients, counselling, residential rehabilitation opportunities and Hepatitis C treatment, 
etc. were offered by needle exchanges, homeless services and community drug projects. Thus, their 
treatment was further complicated with little integration or communication. It is this poor form of treatment 
where dignity, respect and meaningful exchange or discussion have been replaced by long term obligations, 
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Part Two  
3.1 Introduction 
Part Two of the Report is a brief synopsis of our earlier rounds of research and an introduction to Participatory 
Action Research (PAR). As a research method that repeats, we will also discuss why we believe it has the key 
attributes required for the continual monitoring of human rights-based treatment. In order to monitor the 
progressive realisation of rights, one must explore past research results and seek trends and patterns from 
the platform and perspective of Human Rights and Equality Legislation. As previously discussed, the 
International Covenant for Economic, Social and Cultural Rights permits for the progressive realisation of 
rights, as such States are expected to operate within their means to protect vulnerable populations. SURIA’s 
inaugural data was accumulated almost a decade ago, thus creating a backdrop against which we can make 
justified inferences regarding the conduct of key actors and stakeholders within this discursive space, 
regarding the realisation of human rights in the lives of those who use MMT services. Despite minor 
“victories” in our attempts to engender a more humane, holistic mode of care (primarily the cessation of 
supervised urinalysis), we now take as a point of departure, the addition of the quantitative data gathered 
by our team in 2012 and 2017, from which we seek these trends, patterns and changes or lack thereof. Prior 
to doing so however, it is perhaps beneficial to provide a concise definition of PAR.  
 
3.2 The SURIA Methodology – Participatory Action Research: 
Prior to our evidence informed inquiry into the patterns, trends and possible improvements in the lives of 
MMT clients, we outline the methodological approach which underpins our work. SURIA is an independent 
group consisting of service users, former service users, medical professionals, service providers and 
community activists, thus our research is informed by peer-led inquiry and research. Participatory Action 
Research (PAR), a cyclic research methodology that is beneficial in research with marginalised and 
disempowered populations is ideally suited to the objectives of this Report and the monitoring objectives of 
SURIA.  PAR is both collaborative and empowering for vulnerable, marginalised populations, (McTaggart & 
Kemmis 2014). In this context, it allows for the voice of the service user to be at the forefront of activism, 
thus reinforcing the mantra of the International service user community; “Nothing about us, without us”. As 
such, PAR enables and allows the service user to magnify and highlight their own perspectives of their 
treatment, granting them a rare chance to have a voice in their treatment narrative and providing the 
platform for that voice to be heard, (McTaggart & Kemmis 2014). In short, PAR is rooted in dialogue and pays 
specific attention to the right to participate, informing an avenue for the voice of those who use services to 
be heard, despite the frequent propensity for this voice to be ignored, (King 2011). Fundamentally, PAR 
consists of a repeating cycle of plan, action, observe and evaluate, (Khandou & Peter 2005). As a monitoring 
methodology which can be informed by both qualitative and quantitative data, PAR allows SURIA to use 
multiple data sets, chronologically arranged, to demonstrate change, examine trends and seek patterns in 
the data our team has collected from service users. We can then make evidence informed claims regarding 
the realisation of rights, the regression of rights and in general, monitor our recommendations and the dignity 
and respect afforded to MMT clients. Through research, SURIA have now collected an array of datasets that 
tell the story of the evolution or changes in MMT over the course of a decade. Most importantly, this is 
according to those that use MMT, as opposed to the normative model of individuals writing about the service 
user. 
Following this decade of planning, action, observation and evaluation, our data now inhabits the space that 
is located between service use and provision, enabling us to discuss the methadone client narrative and the 
many nuances and contradictions it often involves. Our inaugural research was conducted in the year of the 




upon which this Report is primarily predicated. However, in order to carry out a convincing analysis, it is good 
practice to include the early research, as it is this which informs our monitoring of the service user experience 
and the often-changing life it creates for clients. Only then can one get a full perspective and overview of the 
progression, regression or efficacy of MMT practices in the past and present. Moreover, PAR enables the 
researcher(s) to continually improve our methodology and the research questions to be better aligned with 
our goals and objectives; rights-based treatment and better monitoring and analysis of the life experiences 
of clients.  
 
FIGURE  17: PARTICIPATORY ACTION RESEARCH (PAR) 
 
  
3.3 Monitoring Progression and The Emergence of “Our Core Principles – 2012 & 
2017: 
Prior to SURIA’s work with IHREC, we conducted two research inquiries in 2012 and 2017, both of which were 
informed by quantitative surveys. Surveys are useful as they elicit large volumes of data, however their 
weakness often lies in the absence of rich, in-depth data. However, the advantage of our peer-led research 
by service users and former service users is that our data can be engaged with by researchers who have 
experience of Irish MMT. Both of these early projects produced the primary findings which have come to 
embody our campaign, aims and objectives, and our four “Core Priorities”.  Furthermore, these findings have 
consistently re-appeared in all additional research carried out by SURIA. From our inception, supervised 
urinalysis and the lack of meaningful discussion with the service provider, choice of treatment and an 
independent, robust avenue for complaint have been found to be embedded in the service user narrative. 
The fact that the four core priorities were central to all research projects, all being repeatedly discussed by 
research participants, confirmed our strategy to underpin our work and campaign by these issues. We now 
return to these priorities, employing them as a lens from which we unpack the progression or regression of 
rights-based treatment. As such, Part Two employs this chronological data across these constants to examine 
and monitor the trajectory of rights-based treatment informed by an evidence base of service user narratives, 




3.3.1 Is the Profile of the Service User Changing? 
Our early research suggested that the majority of clients were male, had been in treatment for between 10 
and 20 years, with 66% of participants “hating” being on methadone in 2012 and 83% of clients evaluating 
their experience of methadone treatment as less than 5/10 on a Likert Scale of 1 to 10.  
This is seen to have changed very little across all data sets, thus we argue that our most recent research is an 
outcome of a continual failure of MMT to re-integrate service users. The result is an alarming 64 of service 
users engaging with MMT for over 10 years and 30% for 20 years or more with the vast majority of these 
service users being unhappy with their treatment. Drawing again from the latest EMCDDA statistics, this 
corresponds to a populace of almost 10,000 public health patients who have engaged with MMT and are 
disillusioned by a lifestyle that has now dominated the majority of their lives.  
 
FIGURE  18: TRACKING THE SERVICE USER PROFILE 
Profile 
 
3.3.2 “Too Entrenched “in Urinalysis? 
All statistical accounts demonstrate similar findings regarding urinalysis, with the 2017 data demonstrating a 
substantial increase in the frequency of the practice from one in twenty to one in four being required to 
provide samples 2-3 times a week. This increase is carried into the latest research. 
FIGURE  19: UNPACKING THE FREQUENCY OF URINALYSIS 
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50% aged between 30- 40 years 
 
 
53% aged between 30 -40 years 
 
 
36% aged 30-40   
57% aged 40-60 
93% over 30 years 
 
66% hate being on methadone 
 
83% rate it less than 5 on scale of                
0 -10 
 
77% rate it 3 or less on scale of 0-5 
 
2012 2017 2019/2020 
51% give samples weekly 
 
56% give samples weekly 
 
45% give weekly samples 
 
6% give samples 2 -3 times per 
week 
22.7% give samples 2-3 times per 
week 





How urinalysis is experienced 
2012 2017 2019/2020 
Detail given: 




More detail given: 
40% do not like it 
50% find it degrading 
27% find it undignified 
23% say it is difficult to do 
44% feel they have no choice 
 
More detail given: 
29% do not like it 
51% find it degrading 
37% find it undignified 
17% say it is difficult to do 
40% feel they have no choice 
94% have experienced negative 
consequences in the past 
 
FIGURE  21: SUPERVISED SAMPLING  - 2012-2020 
Supervised urines 







54% supervised with mirrors 65% supervised with mirrors 7% supervised with mirrors 
 
  65% heat bottles 
 
 
The more detailed surveys advanced by PAR have the obvious result of producing a more nuanced inquiry. 
We argue that urinalysis informs many of the problematic issues experienced by Service Users in the MMT 
system and that despite the international evidence (Ward, Mattick & Hall 1998) and the feelings of dis-
respect, the lack of dignity and the negative connotations that are related to the practice, it is still central to 
the system. From the perspective of monitoring the realisation of rights-based, meaningful treatment, 
unpacking these statistics demonstrates that there has been little tangible change in how the service user is 
treated by service providers. As an independent monitoring group SURIA applaud the reduction of supervised 
urinalysis across the vast majority of services, yet we seek complete cessation of the practice. 
3.3.3 Meaningful, Choice Driven MMT: An Overview 
Meaningful discussion and the promotion and development of a positive therapeutic alliance between client 
and service provider is indicative of evidence-based care, where quality of life becomes the main aim of 
effective MMT, (Ward, Mattick & Hall 1998, Dole & Nyswander 1980). Unfortunately, the contemporary Irish 
MMT apparatus has seemingly replaced these with urinalysis, little meaningful review of treatment (30% of 
participants claimed to have had little treatment review with their service providers in 2017, down from 57% 
in 2012) and therefore poor communication and choice. An examination of care plans and meaningful 
discussion conveys a consist low level of goal-driven treatment since our inaugural research, while also 









FIGURE  22: CARE PLANS AND CHOICE 
Care Plans 
2012 2017 2019/20 
62% were never offered care 
plan 
76% never offered care plan 
 
65% never discussed a care plan 
with anyone 
 
 75% would like one 
 
69% do not know what a care plan 
is 
 
 81% have personal goals relating 
to treatment, home family life, 
work, return to education 
 
85% have personal goals relating 
to treatment, home family life, 
work, return to education 
 
 
The vast majority of participants reported that MMT had become a barrier to progression in life (94%), 
while 95% of clients who took part were unemployed. The evidence suggested that MMT was now 
becoming a mode of care that was suppressing clients, with many feeling they were being treated as 
criminals with automatic aspersions being cast upon their character.  
FIGURE  23: CLIENTS IN EMPLOYMENT /TRAINING /EDUCATION 
Employment /training /education 
2012 2017 2019/20 




96% not education, employment, 
or training 





Our research has always been consistent with that of Dole and Nyswander (1980:260), who stated that when 
methadone patients are mistreated, adversary relationships will develop as clinics rapidly become the 
“places of nuisance” which we have discussed.  The client often lives a life of constant sampling, reward and 
sanction. As such, our research suggests that many live a life of restricted choice, little dignity, stigma and 
oppression. Furthermore, the fundamentals of the normative standards of public health care are rarely 
afforded to them. Figure 24 demonstrates how clients felt as participants in their own care. The lack of service 
user input is indicative of a mode of Public Care that considers clients as passive recipients of care as opposed 
to the consumers of a health service which should underpin client-centred recovery.  
The steady increase to almost the entire research population maintaining that they have little input or 
participate is noted by SURIA. We regard this trend as being synonymous with the emergence of a more 








Meaningful participation in treatment 
2012 2017 2019/20 
83% never asked opinion 
 
84% never asked opinion 
 
96% never asked opinion 
 
FIGURE  25: LACK OF ALLIANCE AND RELATIONSHIP 
Relationship with doctor 
2012 2017 2019/20 
43% say they do not have a 
meaningful relationship with 
their doctor 
 
70% say they do not have a 
meaningful relationship with 
their doctor 
 
45% rate their relationship with 
their doctor as between average 
and very poor 
 
As discussed, it was from data elicited from these early rounds of research that would form the fundamental 
underpinnings of what would become the basis of SURIA’s work and campaigns, which included radio 
coverage and taking part in an Oireachtas briefing, as we continued with our objective of framing Irish MMT 
within human rights, incorporating dignity, respect, participation and choice. The evidence highlighted the 
many difficulties and frequently harmful and risky outcomes of being a methadone client. Therefore, our 
continued point of departure encompassed the delivery of services, the lack of evidence-based practice and 
the reluctance of the Health Sector to employ the recommendations of The Farrell Report, a 2010 HSE funded 
evaluation of the Irish MMT regime.  
 
3.4 The Public Sector Duty and MMT – Our Lives, Our Voice, Our Say (2018): 
Our 2012 and 2017 research allowed SURIA to frame the Irish service user narrative within human rights. As 
such, both informed a platform from which Irish MMT could be explored under The Right to Health and The 
Right to Participate. Both are enshrined and ratified by a number of human right instruments. However, as 
this campaign was part of a pilot study of The Public Sector Duty, Article 42 of The Irish Human Rights and 
Equality Act within drug services, this was the principal focus of this peer-led, mixed methods informed 
research. As methadone services are Public Services or Bodies, the Duty was considered to be a human rights 
tool which was ideally suited with the aims, objectives and envisioned values of SURIA. The Public Sector 
Duty maintains that Public Bodies provide services where the service user is treated with respect and non-
discrimination, while simultaneously they are expected to frame their services within the parameters of 
human rights. As duty bearers, services must standardise their practices, thus sustaining a therapeutic 
environment that enables the client to both realise and enjoy rights, as rights holders.  
In general, the 2018 study further confirmed that the practices of some MMT services, as Public Bodies with 
a duty of equality and accountability, were continuing with modes of service provision that were precluding 
rights, with the Report further reinforcing our four basic tenets once more. Drawing from the viewpoint of 
progressive realisation, SURIA consider the Public Sector Duty to be a potential key instrument in the 
development of more client orientated service provision. The Report concluded with twenty-eight 
recommendations which we maintain are precursory to rights-based treatment. Recommendations are 
advantageous in monitoring both our work and the trajectory of rights-based care. We argue that the 2020 
research suggests that services, “as highlighted in the” Farrell Report and other external evaluations (eg 
Priyadarshi 2012), routinely fail to follow international evidence and best practice and that this reflected in 




SURIA propose that participation, accountability, non-discrimination, equality and legality should be tangible 
entitlements of those who engage with the methadone system. We advocate for the methadone client to be 
a Public Health consumer who enjoys equal treatment and entitlements to those who engage with other 
modes of Public Health and Public Services. As such, The Public Sector Duty is pertinent and vital to our work. 
We argue that this Article is ineffective lest Duty Bearers are monitored and held accountable by the relevant 
stakeholders. As such, Public Bodies must have their service provision cogently policed. As an advocacy 
group, who regularly engage with service users, informing them of their entitlements and rights we will 
continue to conduct research and disseminate our results, seeking change, transition and service provision 
which is conducive with 28 key recommendations around which we could pivot our monitoring of MMT 
services. The fourth priority, the implementation of an effective complaint’s procedure, is vital to the service 
user journey that we are trying to highlight. Not having the knowledge or ability to complain reinforces a 
level of docility in the service user voice. We argue it prevents this voice from being heard and enables non-
accountability. Again, unpacking this over a decade reinforces our general consensus and key thesis that 
progressive realisation is not part of the policy development, implementation or service provision. Our hope 
is that this Report will continue to magnify and amplify the voice of the service user. We seek a public health 
service that aligns with others, treats MMT clients as other patients of public health, with respect, dignity 







In conclusion, this research, as both a stand-alone piece, and part of a longer-term monitoring of the 
progression of human rights in the lives of Irish methadone clients presents the Irish system as one in need 
of serious reform.  
Clients, many desensitised or unaware of the ethos and objectives of holistic methadone care are staying on 
methadone for long periods, providing an unacceptable amount of samples, have a low quality of life and are 
rarely enjoying a life where their rights are being realised and a meaningful form of recovery is an attainable 
goal. Instead, our research concludes that Irish MMT has become consistent with the traditional analogy of 
“liquid handcuffs”. Many participants used this metaphorical symbol to describe their life on methadone.  
The spectre of abstinence, and the prohibitive mind-set appears to still dominate, and while SURIA’s earlier 
work around supervised urinalysis seems to have engendered some progressive change, choice of treatment, 
meaningful review and an independent, robust complaint’s procedure are still not being enjoyed by many 
service users.  
The life narrative and experience of our participants is rarely seen as an attractive alternative to illicit drug 
use and outcomes appear poor. Participants allude to being controlled and disallowed from re-integrating 
with the labour market due to the obligations and demands that many services place upon them. As such, 
long term treatment with no tangible improvement in their lives was the frequent postulation. The 
accumulation of recovery capital and any level of social re-integration should be expected to be the minimum 
expectancy of services. Both would promote methadone as an attractive alternative to drug use. The 
contemporary Irish drug clinic fails to promote this mindset, the effect being long term MMT with little 
progression or change, a low standard of life, the non-realisation of basic human rights and a lifestyle that 
consists of repeated visits to doctors, pharmacies, clinics etc.  
While SURIA, as a service user advocacy group, with an strong conceptual framework of rights-based 
treatment are highly critical of Irish methadone services, we do feel it is important to note that we recognise 
the potential for substitution therapy and distance ourselves from the stigmatising anti-methadone stance 
that dominates our country, (Carlin 2005, Bryan et al. 2000). We are critical of key actors, stakeholders, policy 
implementation and development and the inept service provision that permeates Irish MMT. As such, we 
recognise the benefits and respect the choice of the individual to avail of the form of care they wish, if that 
is their decision. Methadone, employed properly, informed by evidence and practiced by well-trained 
practitioners will or should, increase the standard of living of the client at a very minimum. If one chooses to 
remain using methadone, we strongly advocate for this right also. However, this Report, and the preceding 
three, illustrate convincingly the many shortcomings and rights violations that are all too common in 
contemporary MMT, while also highlighting that the methadone system, as a collection of obligation, duties 
and practices is not in the process of progressive realisation.  
Furthermore, our research alludes to a slight regression in almost all areas of treatment. we again call for key 
actors to be held accountable, we again echo the 28 Recommendations of Our Life, Our Voice, Our Say and 
we re-iterate our primary objective of providing an outlet for those whom rarely enjoy treatment informed 
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The 28 Recommendations of Our Lives, Our Voice, Our Say 
Supervised and frequent urine sampling (Chapter 5) 
Based on the lived experience of people availing of drug services of urine sampling as degrading and 
inhuman; and  
Highlighting that the HSE commissioned ‘Farrell Report’ and HSE ‘Clinical Guidelines for Opioid Substitution 
Treatment’ both recognise that urine analysis may be conducted in an inhuman and degrading manner, and 
with a frequency that is unnecessary; 
The project steering committee: 
1. Calls for an immediate cessation to the practice of supervised urine sampling by all drug treatment 
service providers 
2. Calls for a cessation to the use of urine sampling as an evidence based approach for clinical decisions in 
relation to the service users, including as the basis for accessing treatment, withdrawing methadone or 
allocating “takeaway” doses to service users and contingency management 
3. Recommends that the HSE provides training and awareness for medical and administrative staff on 
more evidence-based approaches to providing adequate levels of treatment and care to service users, 
including the limitations of urine sampling as a condition for service users accessing treatment 
4. Recommends that the HSE provides training and awareness for medical and administrative staff on the 
diverse experience of people accessing drug services, including specific issues arising from urine 
sampling for particular groups - for example, women, transgender people, people with disabilities or 
people who may have suffered abuse 
5. Recommends that the HSE provides training and awareness for service providers on the limitations of 
urine sampling and resulting barriers to accessing important supports when urine sampling is used as a 
criteria to determine access to services such as, for example, women’s refuges 
6. Recommends that the HSE actively promote a culture of dignity, respect and equality of participation 
for service users in the development and delivery of care plans and treatment to service users 
 
Meaningful engagement and participation for service users (Chapter 6) 
Based on the lived experience of people availing of drug services of the key role that a positive and 
supportive relationship between people accessing drug treatment services and people providing drug 
treatment services (including doctors and staff in clinics and pharmacies) plays in terms of human dignity 
and drug treatment; and  
Highlighting that the HSE ‘Clinical Guidelines for Opioid Substitution Treatment’ recognise the importance 
of dignity when engaging with service users, including building trust and adjusting the nature of 
interventions to suit individual service users; 
Recognising the important role that integrating treatment with participation in employment, education and 
family and community life can have for recovery and recognising that the HSE commissioned ‘Farrell 
Report’ recommends that an integrated services approach should account for family, community and user 
groups as well as a service model outside of Dublin; 
The project steering committee:  
7. Calls for the HSE to ensure an end to the culture of blame, stigma and punishment that is reflected in 




8. Calls for the HSE to put a greater emphasis on building a positive relationship and open dialogue 
between service users and service providers and for deeper and more meaningful service user 
engagement.   
9. Calls for an immediate cessation to the partial or full suspension of medical treatment by service 
providers or by pharmacies as a reaction to anti-social behaviour. This includes restricting methadone 
takeaways as a form of punitive action. 
10. Recommends the HSE uses the evidence contained in this report as the basis for assessing how current 
treatment structures impact negatively on the lives of service users, or potential service users.   
11. Recommends, based on an assessment as outlined above, a redesign of current treatment and 
dispensing structures that better facilitate the participation of service users in living a more dignified 
and fulfilled life.   
12. Recommends that that HSE design and promote dispensing and treatment structures that are person-
centred and flexible, recognise the diversity of service users and aim to facilitate service users to 
engage in employment, training, education and carrying out family and caring duties. 
13. Recommends that the HSE ensure greater flexibility in how services are delivered and a choice of 
services to accommodate the diversity of peoples’ health needs and circumstances. This includes, for 
example, meeting gender specific needs; meeting the needs of people with disabilities; taking into 
account family or work commitments; and taking into account issues arising from the geographical 
distance between treatment services and where service users are living.   
14. Recommends the provision of financial assistance for service users who have to travel to treatment 
clinics or dispensing pharmacies to avail of services that are not locally available. 
15. Calls for the findings of this report to be widely disseminated to both medical and administrative staff 
in all drug treatment services in Ireland with a view to encouraging a service wide shift to a more client-
centred service delivery model.  
16. Calls for the HSE to actively support and resource the empowerment of service users with a view to 
building and developing the leadership of service users to self-advocate and support other service users 
to do the same.   
17. Calls for the HSE to recognise the value of consultation and that service users are diverse and are not 
represented by one umbrella organisation.  
18. Recommends that the HSE put in place a multi-pronged approach to facilitate the participation of 
service users that draws on a range of engagement approaches. For example, consultation should 
include a number of opportunities for participation such as engagement with individual services users 
across different services and geographical locations, focus groups with service users accessing different 
services and focus groups with a range of organisations representing or providing supports to service 
users. 
 
Treatment choice and treatment plans (Chapter 7) 
Based on the lived experience of people availing of drug treatment services of lack of information and 
engagement with their treatment plans;  
Highlighting that the HSE commissioned ‘Farrell Report’ recommends the need to develop a more 
structured care planning process and care plans subject to regular review and update; and 
Highlighting that the HSE ‘Clinical Guidelines for Opioid Substitution Treatment’ recognise that service users 
should be fully involved in the development of their care plans, setting appropriate treatment goals and 
reviewing their progress in treatment; 
The project steering committee: 
19. Recommends the HSE engage with service users to review the provision of information on treatment 




residential and community detox - and ensure it is accessible and usable for all service users in all drug 
treatment services.  
20. Recommends that the HSE ensure that when people start drug treatment, and at regular intervals 
thereafter, the implications for the different treatment choices available are more thoroughly discussed 
with them and reviewed regularly as their individual needs and circumstances change, ending the 
uniform approach to treatment. 
21. Calls for the HSE to offer more flexible treatment options at more regular intervals taking into account 
the changing life circumstances, opportunities and challenges that are present at different stages in a 
person’s life, particularly given the length of time that a person can be in opiate treatment. 
22. Recommends that the HSE conduct a review of methadone dispensing practices, taking into account 
that supervised daily doses runs entirely counter to a holistic approach to treatment with a significant 
impact on the overall wellbeing of people using drug services and are a barrier to effective participation 
in employment, education, society, and family life.  This review should take into account that most 
people availing of methadone treatment are stable and should not be required to attend every day for 
their daily doses. It should also consider, in particular, if consultation rooms could be used when 
dispensing methadone or if this could be more easily managed if the tablet form of methadone was 
available, as is the case with many other European countries. 
23. Recommends that the HSE ensures that all drug treatment services provide meaningful holistic care 
plans that are informed by service users’ personal goals and are clearly documented in an accessible 
manner and are subject to regular review and update.   
24. Recommends that physical copies of care plans are made available to services users, and not just 
available on computers. 
 
An effective complaints mechanism (Chapter 8) 
Based on the lived experience of people availing of drug services of the lack of information about how to 
make a complaint and the fears about making a complaint; 
Highlighting that the HSE commissioned ‘Farrell Report’ recognises the need to review the lines of reporting 
and accountability in all of the services; and  
Highlighting that the recommendations on how public hospitals could improve their complaints processes 
set out in the 2015 Ombudsman Office could inform improvement of complaints processes in drugs 
services; 
The project steering committee: 
25. Recommends that the HSE engage with service users to develop and implement a positive action plan 
to ensure that information on a complaints system is available in an accessible manner. 
26. Recommends that the HSE ensure that all drug services create a supportive, open and transparent 
environment and culture to lessen fear and perceptions that there will be negative consequences / 
reprisals for making a complaint.  
27. Recommends that the HSE ensure that all service users are informed of their right to make a complaint.  
This may include holding meetings to ensure that service users know how to make a complaint and are 
introduced to their complaints officer.  Care should be taken to avoid conflicts of interest between 
complaints officers and patient advocates (and review officers) so that there is an independent system 
of complaints. 
28. Recommends that the HSE ensure that service providers publish statistics, case studies and audits of 
complaints made by service users and use this information to inform their assessment of equality and 
human rights issues as part of their Public Sector Equality and Human Rights Duty under Section 42 of 
the Irish Human Rights and Equality Commission Act 2014.  
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